The NR4A subclass of nuclear receptor (NR) transcription factors (Nurr1, Nur77 and NOR-1) have essential roles in the development, regulation and maintenance of many aspects of mammalian physiology. NR4As are especially abundant in the central nervous system (CNS) and play critical roles in brain development and maintenance. Therapeutics targeting NR4A activity may hold utility in treatment of Parkinson's disease (afflicts 1 million people in the US) and schizophrenia (afflicts >3 million people in the US). The NR4As are also expressed in skeletal muscle, adipose, cardiovascular, kidney and liver tissues, including aberrant expression in inflamed disease tissues, suggesting utility forNR4A modulators to treat inflammation, arthritis, cancer, and metabolic conditions (dysli idemia, obesity, diabetes and cardiovascular disease). However, efforts to probe the ligandability and drugga- bility of the NR4As have been significantly stunted because they are classified as orphan receptors. Thus far, no endogenous (natural) NR4A ligands have been discovered, and it is believed the NR4As function independent of binding ligand. This orphan classification was made in part based on a crystal structure of apoNurr1, which indicates Nurr1 lacks physical space within the conserved ligand biding pocket region used by nonorphan NRs to bind endogenous ligands. Although the apoNurr1 crystal structure shows a collapsed ligandbinding pocket, NMR studies indicate this region is dynamic on the s-ms timescale, suggesting the ability to expand. Our preliminary work using an array of structural and functional approaches shows that Nurr1 can bind an endogenous ligand in its putative LBP and that endogenous ligands can affect Nurr1 function. Our data also indicate that Nurr1 and Nur77 may have different specificities for endogenous ligands. Detailing the structural mechanism and function of endo- genous ligands targeting the NR4As will demonstrate these orphan receptors are indeed ligand regulated and empower others to use these natural chemical tools to explore NR4A function in vivo. We propose a multidisciplinary approach combining structural biology with biochemical, biophysical and cellular assays to determine the ligand specificity, structural and functional effects, and cellula outcomes of endogenous ligands targeting the NR4As. Outcomes from these studies would demonstrate that the NR4As are bone fide ligand-binding receptors. Because NRs with known endogenous ligands are targets of significant number of current FDA approved drugs (estimated at 13% in 2006), this knowledge will stimulate the development of NR4A drug targeting strategies for Parkinson's disease, schizophrenia, and other human health conditions.

Public Health Relevance

This project focuses on several 'orphan' receptors so called because their natural ligands in the human body are unknown implicated as drug targets for Parkinson's disease, schizophrenia, inflammation, arthritis, cancer, and metabolic conditions (dyslipidemia, obesity, diabetes and cardiovascular disease). Other related receptors with known natural ligands are the targets of a significant number of current FDA approved drugs. Therefore, detailing how natural ligands bind to and affect the function of these 'orphan' receptors will stimulate the development of new drug targeting strategies for a variety of human health conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM114420-02
Application #
9070004
Study Section
Macromolecular Structure and Function B Study Section (MSFB)
Program Officer
Wehrle, Janna P
Project Start
2015-06-01
Project End
2019-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Scripps Florida
Department
Type
DUNS #
148230662
City
Jupiter
State
FL
Country
United States
Zip Code
33458
Hudson, William H; Vera, Ian Mitchelle S de; Nwachukwu, Jerome C et al. (2018) Cryptic glucocorticoid receptor-binding sites pervade genomic NF-?B response elements. Nat Commun 9:1337
Patil, Dipak N; Rangarajan, Erumbi S; Novick, Scott J et al. (2018) Structural organization of a major neuronal G protein regulator, the RGS7-G?5-R7BP complex. Elife 7:
de Vera, Ian Mitchelle S; Zheng, Jie; Novick, Scott et al. (2017) Synergistic Regulation of Coregulator/Nuclear Receptor Interaction by Ligand and DNA. Structure 25:1506-1518.e4
Weikum, Emily R; de Vera, Ian Mitchelle S; Nwachukwu, Jerome C et al. (2017) Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes. Nucleic Acids Res 45:8596-8608
Hudson, William H; Kossmann, Bradley R; de Vera, Ian Mitchelle S et al. (2016) Distal substitutions drive divergent DNA specificity among paralogous transcription factors through subdivision of conformational space. Proc Natl Acad Sci U S A 113:326-31
de Vera, Ian Mitchelle S; Giri, Pankaj K; Munoz-Tello, Paola et al. (2016) Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1. ACS Chem Biol 11:1795-9
Hughes, Travis S; Wilson, Henry D; de Vera, Ian Mitchelle S et al. (2015) Deconvolution of Complex 1D NMR Spectra Using Objective Model Selection. PLoS One 10:e0134474
Kojetin, Douglas J; Matta-Camacho, Edna; Hughes, Travis S et al. (2015) Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat Commun 6:8013